NIH #5R21AR081990-02
Elucidation of the role of Creb5 in promoting the formation and patterning of the intervertebral disc
Expiring Soon
- Amount
- $217K
- Period
- 2023-09-01 → 2026-07-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at HARVARD MEDICAL SCHOOL
NIH #1R01CA307311-01
Identifying and characterizing a stimulatory immune checkpoint in macrophage immunosurveillance
Active
- Amount
- $734K
- Period
- 2026-06-01 → 2031-05-31
- PIs
- 2
- Est. capacity / PI
- ~6 students
Awarded at BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
NIH #5R35GM128641-08
Structure, pharmacology and signaling of G protein-coupled receptors (GPCRs) in inflammation
Active
- Amount
- $420K
- Period
- 2018-08-01 → 2028-12-31
- PIs
- 1
- Est. capacity / PI
- ~1 students
Awarded at UNIVERSITY OF PITTSBURGH AT PITTSBURGH
NIH #5R35GM128641-07
Structure, pharmacology and signaling of G protein-coupled receptors (GPCRs) in inflammation
Active
- Amount
- $420K
- Period
- 2018-08-01 → 2028-12-31
- PIs
- 1
- Est. capacity / PI
- ~1 students
Awarded at UNIVERSITY OF PITTSBURGH AT PITTSBURGH
NIH #3R35GM128641-06S1
Structure, pharmacology and signaling of G protein-coupled receptors (GPCRs) in inflammation
Active
- Amount
- $231K
- Period
- 2018-08-01 → 2028-12-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF PITTSBURGH AT PITTSBURGH
NIH #2R35GM128641-06
Structure, pharmacology and signaling of G protein-coupled receptors (GPCRs) in inflammation
Active
- Amount
- $435K
- Period
- 2018-08-01 → 2028-12-31
- PIs
- 1
- Est. capacity / PI
- ~1 students
Awarded at UNIVERSITY OF PITTSBURGH AT PITTSBURGH
NIH #1R21CA299543-01
Develop positive allosteric modulators to enhance XCR1 signaling in cancer
Active
- Amount
- $409K
- Period
- 2025-06-01 → 2027-05-31
- PIs
- 1
- Est. capacity / PI
- ~3 students
Awarded at UNIVERSITY OF PITTSBURGH AT PITTSBURGH
NIH #5U01DA052329-05
Cannabinoid CB2 Receptor Structure and Allosteric Modulators
Active
- Amount
- $633K
- Period
- 2021-07-15 → 2027-04-30
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF PITTSBURGH AT PITTSBURGH
NIH #5R01AI163011-05
Development of multivalent, ultrapotent nanobody cocktails for SARS-CoV-2 neutralization
Active
- Amount
- $545K
- Period
- 2022-02-09 → 2027-01-31
- PIs
- 3
- Est. capacity / PI
- ~0 students
Awarded at ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
NIH #5R01AI163011-04
Development of multivalent, ultrapotent nanobody cocktails for SARS-CoV-2 neutralization
Active
- Amount
- $535K
- Period
- 2022-02-09 → 2027-01-31
- PIs
- 3
- Est. capacity / PI
- ~0 students
Awarded at ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
NIH #5R01AI163011-03
Development of multivalent, ultrapotent nanobody cocktails for SARS-CoV-2 neutralization
Active
- Amount
- $587K
- Period
- 2022-02-09 → 2027-01-31
- PIs
- 3
- Est. capacity / PI
- ~0 students
Awarded at ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
NIH #7R01AI163011-02
Development of multivalent, ultrapotent nanobody cocktails for SARS-CoV-2 neutralization
Active
- Amount
- $615K
- Period
- 2022-02-09 → 2027-01-31
- PIs
- 3
- Est. capacity / PI
- ~0 students
Awarded at ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
NIH #5R01DA052329-04
Cannabinoid CB2 Receptor Structure and Allosteric Modulators
- Amount
- $633K
- Period
- 2021-07-15 → 2026-04-30
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF PITTSBURGH AT PITTSBURGH
NIH #5R01DA052329-03
Cannabinoid CB2 Receptor Structure and Allosteric Modulators
- Amount
- $633K
- Period
- 2021-07-15 → 2026-04-30
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF PITTSBURGH AT PITTSBURGH
NIH #5R01DA052329-02
Cannabinoid CB2 Receptor Structure and Allosteric Modulators
- Amount
- $632K
- Period
- 2021-07-15 → 2026-04-30
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF PITTSBURGH AT PITTSBURGH
NIH #1R01DA052329-01A1
Cannabinoid CB2 Receptor Structure and Allosteric Modulators
- Amount
- $624K
- Period
- 2021-07-15 → 2026-04-30
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF PITTSBURGH AT PITTSBURGH
NIH #1R21AR081990-01A1
Elucidation of the role of Creb5 in promoting the formation and patterning of the intervertebral disc
- Amount
- $186K
- Period
- 2023-09-01 → 2025-07-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at HARVARD MEDICAL SCHOOL
NIH #5R35GM128641-05
Structure, pharmacology and signaling of G protein-coupled receptors (GPCRs) in inflammation
- Amount
- $391K
- Period
- 2018-08-01 → 2023-07-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF PITTSBURGH AT PITTSBURGH
NIH #5R35GM128641-04
Structure, pharmacology and signaling of G protein-coupled receptors (GPCRs) in inflammation
- Amount
- $391K
- Period
- 2018-08-01 → 2023-07-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF PITTSBURGH AT PITTSBURGH
NIH #5R35GM128641-03
Structure, pharmacology and signaling of G protein-coupled receptors (GPCRs) in inflammation
- Amount
- $391K
- Period
- 2018-08-01 → 2023-07-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF PITTSBURGH AT PITTSBURGH
NIH #5R35GM128641-02
Structure, pharmacology and signaling of G protein-coupled receptors (GPCRs) in inflammation
- Amount
- $391K
- Period
- 2018-08-01 → 2023-07-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF PITTSBURGH AT PITTSBURGH
NIH #1R03TR003306-01A1
Structure and pharmacology of GPR32 in the resolution of inflammation
- Amount
- $157K
- Period
- 2021-04-15 → 2022-03-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF PITTSBURGH AT PITTSBURGH
NIH #1R01AI163011-01A1
Development of multivalent, ultrapotent nanobody cocktails for SARS-CoV-2 neutralization
- Amount
- $769K
- Period
- 2022-02-09 → 2022-02-18
- PIs
- 3
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF PITTSBURGH AT PITTSBURGH
NIH #3R41EY029176-01S1
A Novel Therapeutic that Harnesses MIcrotubules to Enhance Corneal Wound Healing Following an Alkaline Burn
- Amount
- $11K
- Period
- 2019-04-01 → 2019-09-29
- PIs
- 3
- Est. capacity / PI
- ~0 students
Awarded at MICROCURES, INC.